TY - JOUR
T1 - Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck
AU - Katada, Chikatoshi
AU - Yokoyama, Tetsuji
AU - Yano, Tomonori
AU - Kaneko, Kazuhiro
AU - Oda, Ichiro
AU - Shimizu, Yuichi
AU - Doyama, Hisashi
AU - Koike, Tomoyuki
AU - Takizawa, Kohei
AU - Hirao, Motohiro
AU - Okada, Hiroyuki
AU - Yoshii, Takako
AU - Konishi, Kazuo
AU - Yamanouchi, Takenori
AU - Tsuda, Takashi
AU - Omori, Tai
AU - Kobayashi, Nozomu
AU - Shimoda, Tadakazu
AU - Ochiai, Atsushi
AU - Amanuma, Yusuke
AU - Ohashi, Shinya
AU - Matsuda, Tomonari
AU - Ishikawa, Hideki
AU - Yokoyama, Akira
AU - Muto, Manabu
N1 - Funding Information:
Funding Supported by a grant from National Cancer Center Research and Development Fund 36 by the Ministry of Health, Labour and Welfare of Japan.
Publisher Copyright:
© 2016 AGA Institute
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Background & Aims Some patients develop multiple squamous cell carcinomas (SCCs) in the upper aerodigestive tract, attributed to field cancerization; alcohol consumption has been associated with this process. We examined the association between multiple areas of dysplastic squamous epithelium with the development of SCC of the esophagus or head and neck cancer, as well as alcohol consumption and smoking. Methods We examined 331 patients with early stage esophageal SCC using Lugol chromoendoscopy to evaluate the dysplastic squamous epithelium in the esophagus. Patients then were assigned to 3 groups, based on the number of Lugol-voiding lesions: A, no lesion; B, 1–9 lesions; or C, 10 or more lesions. Participants completed lifestyle surveys on their history of drinking, smoking, and diet. All participants were evaluated by laryngopharyngoscopy before registration; only those without head and neck cancer were included, except for patients with superficial SCC limited to the subepithelial layer. Lesions detected in the esophagus and head and neck by surveillance were considered to be metachronous. The study end point was the cumulative incidence of metachronous SCCs in the esophagus and head and neck after endoscopic resection of esophageal SCC, according to the grade of Lugol-voiding lesions. At study entry, all patients were instructed to abstain from alcohol and smoking. Results Over the 2-year study period, metachronous SCCs of the esophagus were detected in 4% of patients in group A, in 9.4% of patients in group B, and in 24.7% of patients in group C (P <.0001 for patients in group A vs B or B vs C). Head and neck SCCs were detected in none of the patients in group A, in 1.7% of the patients in group B, and in 8.6% of the patients in group C (P =.016 for patients in group A vs C and P =.008 for patients in group B vs C). SCC of the esophagus or head and neck developed in 4.0% of patients in group A, in 10.0% of patients in group B, and in 31.4% of patients in group C (P <.0001 for group A vs B or A vs C). Alcohol abstinence decreased the risk of multiple SCCs of the esophagus (adjusted hazard ratio, 0.47, 95% confidence interval, 0.25–0.91; P =.025), whereas smoking abstinence did not. Conclusions Multiple dysplastic lesions in the esophagus increase the risk of multiple SCCs. Alcohol abstinence reduces the risk of metachronous SCCs. Clinical Trials registry: UMIN000001676 and UMIN000005466.
AB - Background & Aims Some patients develop multiple squamous cell carcinomas (SCCs) in the upper aerodigestive tract, attributed to field cancerization; alcohol consumption has been associated with this process. We examined the association between multiple areas of dysplastic squamous epithelium with the development of SCC of the esophagus or head and neck cancer, as well as alcohol consumption and smoking. Methods We examined 331 patients with early stage esophageal SCC using Lugol chromoendoscopy to evaluate the dysplastic squamous epithelium in the esophagus. Patients then were assigned to 3 groups, based on the number of Lugol-voiding lesions: A, no lesion; B, 1–9 lesions; or C, 10 or more lesions. Participants completed lifestyle surveys on their history of drinking, smoking, and diet. All participants were evaluated by laryngopharyngoscopy before registration; only those without head and neck cancer were included, except for patients with superficial SCC limited to the subepithelial layer. Lesions detected in the esophagus and head and neck by surveillance were considered to be metachronous. The study end point was the cumulative incidence of metachronous SCCs in the esophagus and head and neck after endoscopic resection of esophageal SCC, according to the grade of Lugol-voiding lesions. At study entry, all patients were instructed to abstain from alcohol and smoking. Results Over the 2-year study period, metachronous SCCs of the esophagus were detected in 4% of patients in group A, in 9.4% of patients in group B, and in 24.7% of patients in group C (P <.0001 for patients in group A vs B or B vs C). Head and neck SCCs were detected in none of the patients in group A, in 1.7% of the patients in group B, and in 8.6% of the patients in group C (P =.016 for patients in group A vs C and P =.008 for patients in group B vs C). SCC of the esophagus or head and neck developed in 4.0% of patients in group A, in 10.0% of patients in group B, and in 31.4% of patients in group C (P <.0001 for group A vs B or A vs C). Alcohol abstinence decreased the risk of multiple SCCs of the esophagus (adjusted hazard ratio, 0.47, 95% confidence interval, 0.25–0.91; P =.025), whereas smoking abstinence did not. Conclusions Multiple dysplastic lesions in the esophagus increase the risk of multiple SCCs. Alcohol abstinence reduces the risk of metachronous SCCs. Clinical Trials registry: UMIN000001676 and UMIN000005466.
KW - Carcinogenesis
KW - Drinking Alcohol
KW - Genetics Methods
KW - Risk Factor
UR - http://www.scopus.com/inward/record.url?scp=84994876234&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84994876234&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2016.07.040
DO - 10.1053/j.gastro.2016.07.040
M3 - Article
C2 - 27492616
AN - SCOPUS:84994876234
SN - 0016-5085
VL - 151
SP - 860-869.e7
JO - Gastroenterology
JF - Gastroenterology
IS - 5
ER -